AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY美国妇产科学杂志

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY(英文缩写 AM J OBSTET GYNECOL),ISSN 0002-9378,eISSN 1097-6868,中文译名:美国妇产科学杂志 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
7.900
JCR 分区
Q1
CAS 分区
B1
近一年发文量
665
本站 PubMed 收录统计

发文量统计区间:2025-11-01 至 2026-10-31,按本站收录文献的发表日期统计。

ISSN: 0002-9378 · eISSN: 1097-6868 · 缩写: AM J OBSTET GYNECOL ·中文: 美国妇产科学杂志

期刊介绍

选择期刊介绍栏目

期刊简介

《American Journal of Obstetrics and Gynecology》是妇产科学领域历史悠久的国际权威期刊,聚焦女性生殖健康、妊娠与分娩、妇科疾病及围产医学等方向。内容涵盖临床研究、转化医学与循证综述,读者主要为妇产科医师、母胎医学专家、生殖医学研究者及相关护理与公共卫生人员。

研究方向

主要发表妇产科与生殖医学领域的原创临床研究、随机对照试验、系统综述、荟萃分析及重要指南性文章,主题包括高危妊娠、早产、妊娠期并发症、妇科肿瘤、生殖内分泌与不孕、盆底医学及女性预防保健等。

期刊特色

研究取向强调临床相关性与方法学严谨,重视大样本、多中心及前瞻性设计,也欢迎机制探索与转化研究。论文通常要求明确的临床意义和统计学规范。适合有较好研究基础、希望在高影响力平台展示成果的妇产科临床医生与科研人员。

投稿难度

投稿难度较高,对创新性、样本量、统计分析和伦理规范均有严格要求。建议在投稿前完善研究设计,突出临床转化价值,并认真回应方法学局限。该刊对语言表达和格式规范也较重视,非英语母语作者宜提前做专业润色。

历年影响因子趋势

JCR 数据年份影响因子JCR 分区
202110.693Q1
20229.800Q1
20238.700Q1
20248.400Q1
20257.900Q1

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 最新收录文献

  1. JCR分区: Q1 CAS分区: B1 影响因子: 7.9

    1. Corrigendum to "Neonatal mortality in the United States is related to location of birth hospital versus home rather than the type of birth attendant" American Journal of Obstetrics and Gynecology 223 (2020) 254.e1-254.e8.

    1. 对《美国新生儿死亡率与出生地点(医院还是家中)相关,而非与接生员类型相关》的勘误,《美国妇产科杂志》223 (2020)
    作者:
    Amos Grünebaum, Laurence B McCullough, Brooke Orosz, Frank A Chervenak
    日期:
    2026-10-03

    该文献暂无摘要。

  2. JCR分区: Q1 CAS分区: B1 影响因子: 7.9

    2. NBN is associated with an increased risk of ovarian cancer (Reply to Letter-to-the-Editor).

    2. NBN与卵巢癌风险增加相关(致编辑信回复)
    作者:
    Subhasheenee Ganesan, Caitlin T Fierheller, D Gareth Evans, Ranjit Manchanda
    日期:
    2026-10-03

    该文献暂无摘要。

  3. JCR分区: Q1 CAS分区: B1 影响因子: 7.9
  4. JCR分区: Q1 CAS分区: B1 影响因子: 7.9

    4. Methodological considerations of NBN-associated ovarian cancer risk (Letter-to-the-Editor).

    4. NBN相关卵巢癌风险的方法学考量(致编辑信)
    作者:
    Jiashuai Wang, Shasha Qiu
    日期:
    2026-10-03

    该文献暂无摘要。

  5. JCR分区: Q1 CAS分区: B1 影响因子: 7.9
  6. JCR分区: Q1 CAS分区: B1 影响因子: 7.9

    6. Survival Outcomes of Ovarian-Sparing Surgery for Early-Stage Adult Granulosa Cell Tumor.

    作者:
    Fiamma L Van Biema, Yongmei Huang, Delanie Ludmir, Kevin J Rouse, Shayan Dioun, Alexander Buckley de Meritens, Thomas Randall, Tarah Pua, Caryn M St Clair, June Y Hou, Koji Matsuo, Dawn L Hershman, Jason D Wright, Xiao Xu
    日期:
    2026-10-02

    Evidence regarding the oncologic safety of ovarian-preserving surgery for the management of early-stage adult granulosa cell tumors remains limited and inconsistent. To examine overall survival among premenopausal patients with early-stage adult granulosa cell tumors undergoing ovarian-sparing surgery (cystectomy or unilateral salpingo-oophorectomy), in comparison to bilateral salpingo-oophorectomy. This retrospective cohort study utilized the National Cancer Database to identify female patients aged 18-49 years with histologically confirmed stage IA or IC adult granulosa cell tumors diagnosed between 2004 and 2021. Patients were categorized by surgical approach: ovarian cystectomy, unilateral salpingo-oophorectomy or bilateral salpingo-oophorectomy. Propensity score-based inverse probability of treatment weighting was used to account for differences in baseline patient characteristics across the surgical groups. Two- and five-year overall survival was estimated based on Kaplan-Meier methods after applying inverse probability of treatment weighting. The association between surgical group and survival was estimated using Cox proportional hazards regression with inverse probability of treatment weighting and adjustment for treatment factors (hysterectomy, lymphadenectomy, and chemotherapy). Of 851 patients identified, 76 (8.9%) underwent cystectomy, 445 (52.3%) underwent unilateral salpingo-oophorectomy and 330 (38.8%) underwent bilateral salpingo-oophorectomy. Concurrent hysterectomy was performed in 82.7% of the bilateral salpingo-oophorectomy group, compared with 22.9% of the unilateral salpingo-oophorectomy group. Younger patients (aged 18-39) more frequently underwent ovarian-sparing procedures, while those aged 40-49 more frequently underwent bilateral salpingo-oophorectomy (P < .001). Median follow-up was 77.5 months (interquartile range: 39.2-135.8). After inverse probability of treatment weighting and adjustment for treatment factors, there was no significant difference in overall survival across the surgical groups (adjusted hazard ratio [95% confidence interval]: 0.72 [0.23-2.28] for cystectomy versus bilateral salpingo-oophorectomy and 1.06 [0.53-2.15] for unilateral salpingo-oophorectomy versus bilateral salpingo-oophorectomy). Findings remained consistent when the analysis was stratified by age (18-39 and 40-49 years) and stage (IA and IC). Among patients aged 18-49 with early-stage adult granulosa cell tumors, ovarian-preserving surgery (cystectomy or unilateral salpingo-oophorectomy) was associated with overall survival comparable to bilateral salpingo-oophorectomy. Further research comparing recurrence and disease-free survival across these surgical groups is needed to facilitate clinical decision-making.

  7. JCR分区: Q1 CAS分区: B1 影响因子: 7.9
  8. JCR分区: Q1 CAS分区: B1 影响因子: 7.9

    8. Transcervical Balloon Cervical Ripening and Risk of Uterine Rupture After Previous Cesarean Delivery: A Systematic Review and Meta-analysis.

    8. 经宫颈球囊促宫颈成熟与既往剖宫产术后子宫破裂风险:一项系统评价和荟萃分析
    作者:
    Jacques Balayla, Allison Engo, Elias M Dahdouh
    日期:
    2026-09-29

    To estimate comparator-specific associations between transcervical balloon cervical ripening and complete uterine rupture during trial of labor after cesarean. PubMed/MEDLINE, Embase, CINAHL, Cochrane CENTRAL, Web of Science, and Google Scholar were searched from inception through June 2026 without language restriction, plus reference lists and trial registries (PROSPERO CRD420261444368). Studies of trial of labor after a previous low-transverse cesarean delivery that used a Foley, single-balloon, or double-balloon catheter for cervical ripening were included. Comparative observational studies with spontaneous labor, oxytocin, or prostaglandins as comparators were included in the quantitative synthesis. Amniotomy alone was a prespecified eligible comparator; however, no study reported a separable amniotomy-only arm, precluding quantitative pooling of this comparison. Single-arm cohorts were summarized descriptively, while randomized trials were synthesized qualitatively. Primary analyses were restricted to studies reporting complete uterine rupture separately. Because balloon placement was followed by amniotomy, oxytocin, or both in nearly every protocol, the exposure is designated a balloon-based induction strategy rather than the catheter in isolation. Risk of bias was assessed with ROBINS-I, the Newcastle-Ottawa Scale, and Cochrane RoB 2; certainty was rated with GRADE. Comparator-specific odds ratios (ORs) and absolute risk differences were estimated with Mantel-Haenszel methods, with Peto and DerSimonian-Laird models as sensitivity analyses; potentially overlapping Swedish cohorts were not pooled. Eighteen nonrandomized studies and two randomized trials contributed 28,035 study observations, including 5,516 balloon exposures. Relative to prostaglandin induction, balloon ripening showed lower odds of complete uterine rupture across three cohorts (Mantel-Haenszel OR, 0.43; 95% confidence interval [CI], 0.26-0.72; risk difference, -19 per 1,000 [95% CI, -31 to -7] across four cohorts); a potentially overlapping Swedish cohort and a cohort reporting a combined rupture/dehiscence endpoint gave concordant estimates, and one trial recorded no ruptures. No difference was detected versus oxytocin alone (OR, 0.24; 95% CI, 0.05-1.18) or spontaneous labor (seven cohorts; OR, 1.29; 95% CI, 0.90-1.84; OR, 1.09 [95% CI, 0.73-1.62] excluding the most influential cohort). Across all pharmacologic comparators the OR was 0.40 (95% CI, 0.25-0.66), whereas dehiscence was reported more often after balloon-based induction (five studies; OR, 1.86; 95% CI, 1.06-3.29), with concordant estimates against oxytocin-based induction (OR, 1.80; 95% CI, 0.83-3.92), spontaneous labor (OR, 2.24; 95% CI, 0.91-5.52), and prostaglandins (OR, 1.09; 95% CI, 0.15-7.84; P = .80 for subgroup difference). Certainty was very low throughout. A balloon-based induction strategy was not associated with an increase in complete uterine rupture compared with spontaneous labor or oxytocin alone and showed lower odds than prostaglandin induction. Because amniotomy, oxytocin, or both almost always followed catheter placement, these estimates cannot be attributed to the catheter alone. Mechanical ripening therefore remains reasonable in carefully selected candidates when induction is indicated, with counseling, continuous monitoring, and immediate access to emergency cesarean delivery.

  9. JCR分区: Q1 CAS分区: B1 影响因子: 7.9

    9. Selective Reduction in Monochorionic Pregnancies With Selective Fetal Growth Restriction: A Systematic Review and Meta-analysis.

    9. 选择性胎儿生长受限的单绒毛膜妊娠中的选择性减胎:系统评价与荟萃分析
    作者:
    Ehsan Rojhani, Claudio V Schenone, Ahmed Hashem Fathallah, Nikan Zargarzadeh, Akihiro Hasegawa, Faezeh Aghajani, Eyal Krispin, Francesco D'Antonio, Hiba Mustafa, Asma Khalil, Ramen H Chmait, Alireza A Shamshirsaz
    日期:
    2026-09-29

    To estimate the rates of co-twin intrauterine fetal demise (IUFD), co-twin neonatal demise, and gestational age (GA) at delivery in monochorionic (MC) pregnancies complicated by selective fetal growth restriction (sFGR) undergoing selective reduction (SR) and stratify the outcomes according to the surgical technique. PubMed, Embase, Cochrane Library, Scopus, and Web of Science were searched from inception through May 2026. Studies were eligible if they reported MC pregnancies complicated by sFGR undergoing SR with data on co-twin IUFD or neonatal demise and GA at delivery. This systematic review and meta-analysis was conducted per PRISMA guidelines and registered on INPLASY (INPLASY202580001). Pooled estimates were calculated using random-effects meta-analysis, and technique differences were evaluated using meta-analytic tests for subgroup differences. Post hoc binomial generalized linear mixed models (GLMMs) assessed the robustness of dichotomous outcomes without continuity correction. I quantified heterogeneity across studies. A total of 22 studies, including 686 pregnancies, met the inclusion criteria and were eligible for quantitative synthesis. The overall rates of co-twin IUFD and co-twin neonatal death were 15% and 4%, respectively, and the GA at delivery was 35.4 weeks (95% CI, 34.2-36.6). In the primary indirect study-level subgroup analysis, pooled co-twin IUFD was higher in RFA than BCC studies (20% vs 9%; P=0.02). In the GLMM sensitivity analysis, the estimated rates remained higher in RFA than BCC studies (14.8% vs 6.6%), but the subgroup difference was not statistically significant (P=0.06). The only direct within-study comparison included 24 sFGR pregnancies and showed no significant difference in co-twin IUFD (BCC, 0/5; RFA, 3/19; P=1.00). Co-twin neonatal death rates were comparable (BCC, 5% vs RFA, 3%). GA at delivery was lower in cases undergoing BCC compared with RFA (34.5 weeks vs 36.8 weeks, respectively; P=0.039). These unadjusted comparisons may be confounded by differences in study and case characteristics. In MC pregnancies complicated by sFGR undergoing SR, pooled risks of co-twin IUFD and neonatal death were approximately 15% and 4%, respectively. The primary analysis suggested lower co-twin IUFD and earlier delivery in BCC than RFA studies; however, the IUFD difference was not statistically significant in the GLMM sensitivity analysis, and all technique comparisons were indirect, unadjusted, potentially confounded , and the single direct comparison was small and inconclusive. Available evidence does not establish an advantage of BCC or RFA.

  10. JCR分区: Q1 CAS分区: B1 影响因子: 7.9

    10. Interpreting the diagnostic performance of angiogenic biomarkers in pregestational diabetes (Letter-to-the-Editor).

    10. 解读血管生成生物标志物在孕前糖尿病中的诊断性能(致编辑信)
    作者:
    Yan Chen, Jingyuan Li, Ting Ye
    日期:
    2026-09-24

    该文献暂无摘要。

在 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊